Usefulness and clinical impact of a fractional flow reserve-targeted strategy for coronary artery stenting: FROST III, a multicenter prospective registry
EuroInterv.2005;1:85-92.
P. Dupouy, MD; M. Gilard, MD; J-F. Morelle, MD; A. Furber, MD, PhD; E. Aptecar, MD; P. Cazaux, MD; M. Slama, MD; L-J. Feldman, MD, PhD; O. Wittenberg, MD; J-M. Pernès, MD; B. Huret, MD; P. Commeau, MD; J. Boschat, MD; E. Teiger, MD, PhD; A. Lafont, MD, PhD; P-G. Steg, MD, PhD; J-L. Dubois Randé, MD, PhD for the FROST 3 investigators
Fédération de cardiologie, AP-HP, CHU Henri-Mondor, Université Paris XIIe, Créteil, France
Background: Fractional flow reserve (FFR) is correlated with angiographic and intravascular ultrasound assessments of stent placement. Post-stenting FFR has been described as a good predictor of clinical events a